Introduction
Rheumatoid arthritis is characterized pathologically by the proliferation of synovial fibroblast-like and macrophage-like cells, and infiltration of the synovium with lymphocytes, predominantly T cells of the helper (CD4+) phenotype (1, 2) . Such CD4+ T cells are typically activated by an antigenic peptide complexed with class Il MHC molecules (HLA-DR/DP/ residues at amino acids 70/71 of the HLA-DRB chain (3) (4) (5) (6) (7) (8) . This association is reminiscent of similar associations seen in experimental models of autoimmunity, such as experimental autoimmune encephalomyelitis, a model for multiple sclerosis triggered by autoreactive T cells reactive to myelin basic protein and specific MHC class II antigens (9) (10) (11) (12) . The observation of a restriction to certain MHCs in such experimental systems often correlates with a restricted repertoire of T cell antigen receptors which respond to that MHC + antigen ( 13) .
This has also been documented in multiple sclerosis T cell lines derived from humans ( 14, 15) . In experimental systems, antibodies directed to the relevant T cell receptors, or immunization with peptides derived from these T cell receptors, is capable of ameliorating the disease (10, 11) . These observations suggest that similar strategies may be applied to human T cell mediated autoimmune diseases.
Molecular characterization of human T cell receptors has been greatly aided recently through the application ofthe polymerase chain reaction (PCR)'. By utilizing oligonucleotide primers specific for the different T cell receptor variable region families, family specific amplification is possible ( 14-16). This technique can be applied to the identification of T cell receptors of interest, as well as aid in the cloning and sequencing of these receptors. The purpose of these studies is to apply PCR with family specific primers to characterize the predominant T cell receptor families present in rheumatoid synovium, with the eventual goal of cloning and sequencing these receptors.
Methods
Synovial tissue and cell lines. Tissue was obtained at the time ofjoint surgery and was handled aseptically at all times. The tissue was rinsed in sterile PBS, and placed in a petri dish. The superficial layer snipped off with scissors and minced with a sterile scalpel. The minced tissue was placed in 20 ml PBS with 5% Hepes buffer, 0.4 g hyaluronidase (type I-S), 0.04 g DNA-ase I (type II from bovine pancrease) and 1.2 g collagenase (type Z) (all from Sigma Chemical Co., St. Louis, MO) with 1% FCS, and stirred continuously for 90 min at 37°C. The large chunks of tissue were decanted, and the cells centrifuged and washed twice in culture media [RPMI 1640 with pen/strep, L-glutamine, sodium pyruvate, nonessential amino acids, Hepes buffer, 5 X 10-' M Bl-mercaptoethanol (all from Gibco Laboratories, Grand Island, NY), and 10% FCS (HyClone Laboratories, Logan, UT)]. T cells were purified by standard nylon wool chromatography ( 17) , cultured overnight at 1 X 106/ml in culture media, and the nonadherent cells were sepa-rated, centrifuged, and maintained in culture. Stimulation of the cells was with either phytohemagglutinin (1% solution, from Sigma), IL-2 (Amgen Biologicals, Thousand Oaks, CA), or media alone. Cells were stimulated for 3-5 d, and then maintained for 1-3 wks in 10 U/ml IL-2 before analysis.
Fluorescence-activated cell sorter (FACS") analysis. After culture, cells were centrifuged, washed, and resuspended in FACSO media ( 1% bovine serum albumin in PBS with 0.1% sodium azide), at 1 X 106 cells per 100 Al. Primary antibody was added for 20-40 min on ice.
After an additional two washings, the cells were subjected to second antibody (fluorescein isothiocyanate-conjugated goat anti-mouse Ig [Sigma]; at a 1:100 dilution), then washed twice again. The cells were analyzed at the University ofPennsylvania Cancer Center fluorescence activated cell sorter facility. Percent positive was determined by comparing the samples to a no primary antibody control. Antibodies used were OKT3 anti-CD3 (Ortho Diagnostic Systems, Inc., Raritan, NJ), Leu3a anti-CD4 (Becton Dickinson, San Jose, CA), and OKT8 (Ortho), at the dilutions suggested by the suppliers.
RNA extraction and cDNA synthesis. Tissue was homogenized in guanidinium isothiocyanate (GITC) solution, or cells resuspended in GITC solution, and vortexed for 30 s. 0.1 ml 2 M sodium acetate pH 4 was added, the solution vortexed, followed by 1 ml diethylpyrocarbonate (DEP)-water-saturated phenol, the sample mixed, then 0.2 ml SE-VAG, thorough vortexing, and the solution transferred to sterile eppendorf tubes. Each sample was then incubated on ice for 20 min, microfuged for 10 min, and the top layer recovered, RNA precipitated with 2.5 vol of 100% ethanol and 1/ 10 vol 1 M sodium acetate pH 5.5 in dry ice/ethanol for 30 min. The solutions were microfuged for 15 min, the supernatant was decanted, the pellets were washed in 70% ethanol, and rotary evaporated. The dried pellets were resuspended in 50 Al DEP-water and RNA quantified spectrophotometrically.
For reverse transcription, 1-20 Mg of RNA in 10 Ml was used to synthesize cDNA primed with random hexamers in the following reaction mixture: 3 Ml Maloney Murine Leukemia Virus reverse transcriptase with 6 Ml 5x reverse transcriptase buffer, 1.5 Ml RNAse inhibitor, and 31A 0.1 M dithiothreitol (all from Gibco/Bethesda Research Laboratories, Gaithersburg, MD), 3,ul random hexamers (from Pharmacia LKB Biotechnology, Piscataway, NJ), and either 1 or 3 Ml 100 mM dNTPs (25 mM in each dNTP, from Boehringer Mannheim GmbH, Mannheim, Germany). After a 10-min preincubation at 25°C, the reaction was carried out for 1 h at 42°C, then 95°C for 5 min followed by storage at -20°C until use.
PCR amplification of T cell receptor variable regions. cDNA was amplified using the primers listed in Table I Transfer andprobing. Agarose gels were transferred to nylon filters (Genescreen Plus) by capillary transfer overnight ( 18, 19) . Hybridization was with either Ca5' or C,5'primers noted in Table I . Oligonucleotide labeling employed 100 ng DNA, 75 ,uCi [32P]ATP, 2.5 tl lOX kinase buffer (500 mM Tris HCL pH 7.6, 100 mM MgCI2, 50 mM dithiothreitol, 1 mM spermadine, 1 mM EDTA), 10 U T4 DNA kinase adjusted to a final volume of 25 ,ul with distilled water. Labeling was carried out by incubation at 37°C for 30 min before use. Blots were prehybridized in 5X standard saline citrate (SSC), 5X Denhardt's solution, 0.1% SDS for 1-1.5 h at 55°C in seal-a-meal bags, most of the solution poured off, 32P-labeled oligonucleotide added (75 uCi) and hybridized for 2-3 h at 42°C or overnight at 4°C, the blots washed once in 2x SSC, 0.1% SDS for 20 min at 45°C, then three times in 5X SSC, 0.1% SDS for 20 min at 45°C, and exposed to Kodak XRP film at -70°C for 2-72 h.
Statistics. The standard error of occurrence of each TCR V region family was calculated by the formula:
where n is the number of samples analyzed, and p is the proportion of positives. The frequency of occurrence of a particular TCR V region family was considered significantly increased if it was 2 2 standard errors higher than the mean for all V regions of that type (a or f3).
Comparisons of rheumatoid and nonrheumatoid synovial TCR expression employed the Student's t test, with correlations between TCR alpha and TCR beta expression employing Chi2 analysis (20) .
Results
PCR primers. We used primers derived from the human TCR alpha and beta constant regions in conjunction with primers specific for individual variable region families ( 14-16). The primers used in these studies are listed in Table I , and their relative positions on the coding strand of cDNA indicated in Fig. 1 The PCR program used in these studies used a low stringency initial five cycles, followed by 40 cycles at higher stringency. The rationale for using this program was twofold. As these studies were designed to investigate the range of T cell receptors expressed in RA synovium, and all TCR V regions have not yet been sequenced, related TCR families which have sequences related to the primers used here may also be amplified in the initial low stringency cycles. 40 cycles of amplification were then used to amplify even low frequency transcripts. This should help overcome the potential problem of sampling error, which is possible from surgical specimens. Thus, if local accumulations of specific TCR bearing T cells are present, and such a local accumulation is missed in the surgical specimen, their presence still may be detected if they are also present at lower frequency in the surgical specimen examined. Preliminary experiments with these primers using the DEGEN2 program revealed that all of them (except V,316) are effective in amplifying TCR V regions from PHA stimulated peripheral blood mononuclear cells, but that only the appropriate V region primers amplified Jurkat cell cDNA TCR ([21] and data not shown).
Synovial Tcell lines. RNA was extracted and cDNA synthesized from both whole synovium and PHA stimulated synovial T cell lines maintained in IL-2 for 1-2 wk before analysis. Synovial T cell lines derived in this manner have been previously described ( 17) and represent a phenotypically mixed population, including CD8+ and CD4+ cells. FACSO analysis was available for four of these cell lines at the time of analysis; data are shown in Table II . In three samples, CD4+ cells predominated, whereas CD8+ cells were more prevalent in a fourth line. T cell receptor transcripts were amplified from cDNA derived from these T cell lines. All rheumatoid synovia were obtained at the time of joint surgery, and thus represented late disease. cDNA was split into equal portions and amplified with the middle constant region primers (CB.id or Camid) in combination with each of the respective individual variable region primers noted in Table I (e.g., C3,.id + C#31, Cfm3d + Cj2, .
Clmid + C1320; Camid + Ca 1, Camid + Ca2, ... Camid + Ca 18). After electrophoresis and transfer, these were probed with Cf35' or Ca5', respectively. Results for the synovial T cell lines are shown in Fig. 2 . An average of 15 alpha chain and 15.8 beta chain families were detected in these cell lines. This suggests that a quite heterogeneous population ofT cells is present in synovium. However, as these cell lines were initially expanded with PHA, it is possible that the proportion of the various TCR subsets alter during culture. In addition, the ability of PHA to activate resting T cells raises concern about the relative proportion of activated T cells following stimulation compared with before stimulation. Therefore, similar analyses (Fig. 3) . Note that the intensity of some bands which appeared in early cycles faded relative to the intensity of bands which arose at later cycles. Thus, the intensity of the bands can not be taken as an indicator of the relative abundance of the corresponding cDNA.
The frequency ofoccurrence ofeach TCR variable region is tabulated for rheumatoid synovial tissue in Tables III and IV 
Discussion
Many lines ofevidence indicate that T cells are involved in the development of rheumatoid joint disease. These include the presence of lymphocytic infiltrates composed primarily of CD4+ T cells in the synovium ( 1, 2, (22) (23) (24) , the linkage ofRA to HLA-DR4 which comprises a ligand for CD4+ T cell receptors (3) (4) (5) (6) (7) (8) , and experimental models of arthritis and related autoimmune diseases that can be transferred by T cell lines ( 10, 12, 13, 25-34). Studies in both animal models and human rheumatoid arthritis indicate that anti-T cell reagents can be of therapeutic efficacy (10, 11, 26, (35) (36) (37) (38) (39) (40) (41) . However, if these reagents are nonspecific and delete too large a portion of the T cell repertoire, immunodeficiency may result. A better therapeutic alternative is to delete only those T cells involved in the autoimmune response. Studies ofrheumatoid T cell receptors suggest a polyclonal or oligoclonal population (3, (42) (43) (44) (45) (46) (47) (48) . These studies generally employed Southern analysis searching for restriction fragment length polymorphisms to determine the oligoclonality of the populations analyzed. Two reports used PCR with family specific primers in analysis of rheumatoid synovial fluid lymphocyte TCRs (46, 49 (Tables III and IV) . None of the samples lacked at least one ofthese T cell receptor chain families. However, some of these same TCR families were also found quite frequently in nonrheumatoid synovial tissue and fluid (Table  V) to note that V 14 and 17 were also found in 100% of the nonrheumatoid specimens. The higher average frequency of TCR V region family expression in the nonrheumatoid specimens makes interpretation difficult, but this may indicate a relative predilection for T cells bearing these receptors to target synovial tissue as a general phenomenon. Such tissue-specific TCR expression has been reported for gamma-delta-T cell receptors (50) , but the significance remains unclear.
The potential existence of rheumatoid-specific T cells, possessing a functional alpha-beta TCR pair, can not be discounted. Such a T cell is likely to include at least one TCR chain which is frequently encountered in multiple different rheumatoid synovial specimens. It is interesting to note that in rheumatoid synovia analyzed herein, there was a significant correlation between expression of Va 17 and V#134 (Chi2 = 3.75, P = 0.05). This correlation was not apparent in the nonrheumatoid synovia, or for the other frequently expressed TCR families in the rheumatoid synovia. As these and other TCRs are further characterized the molecular basis for autoreactivity and association with HLA-DR4 may be appreciated. Reagents and therapies designed to specifically target the T cells which bear these T cell receptors should be of use in further delineating the function of these cells, and may be efficacious in ameliorating some of the disease manifestations of rheumatoid arthritis.
